美国小组推荐新的抗乙型肝炎成人疫苗

StephenW

US panel recommends new adult vaccine against Hepatitis B
Posted: Feb 22, 2018 11:04 PM
Updated: Feb 22, 2018 11:06 PM


NEW YORK (AP) - A federal advisory panel is recommending a new vaccine against Hepatitis B.
   
The vaccine called Heplisav-B was licensed in November and is the first new hepatitis B vaccine in 25 years.
   
Hepatitis B vaccines have been in childhood shots for decades. The new vaccine is for adults.
   
The hepatitis B virus can damage the liver and is spread through contact with blood or other bodily fluids. Cases have been rising, a trend linked to the heroin and opioid epidemic. Meanwhile, researchers found older vaccines falter in diabetics and older adults.
   
The new vaccine uses an additive that boosts the body's immune response. It is two shots given over one month.
   
The Advisory Committee on Immunization Practices endorsed the vaccine Wednesday in Atlanta. The government usually adopts its recommendations.

Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

美国小组推荐新的抗乙型肝炎成人疫苗
发布时间：2018年2月22日11:04 PM
更新日期：2018年2月22日晚上11点06分


纽约（美联社） - 一个联邦咨询小组正在推荐一种针对乙型肝炎的新疫苗。
   
名为Heplisav-B的疫苗于11月获得许可，是25年来第一个新的乙型肝炎疫苗。
   
乙肝疫苗几十年来一直处于童年时期的注射状态。新疫苗是针对成年人的。
   
乙型肝炎病毒可损伤肝脏并通过接触血液或其他体液传播。案件一直在上升，这与海洛因和阿片类流行病有关。与此同时，研究人员发现老年疫苗在糖尿病患者和老年人中动摇。
   
新疫苗使用一种能够增强机体免疫反应的添加剂。这是两个投篮超过一个月。
   
免疫实践咨询委员会周三在亚特兰大批准了疫苗。政府通常采纳其建议。

版权所有2018年美联社。版权所有。本资料不得发表，广播，重写或重新分发。